Obama's $63 billion global health initiative 'will sustain' PEPFAR, editorial says

"President Obama's push to reenergize the fight against the AIDS epidemic in the United States led to concern that he was going to allow U.S. global leadership in fighting the disease to languish," a Washington Post editorial says, adding, "Those fears ought to be calmed after Mr. Obama's announcement Tuesday of an initiative that will sustain" the President's Emergency Plan for AIDS Relief.

PEPFAR is a "successful" and "groundbreaking program" that a recent study found prevented about 1.2 million deaths, the editorial says. It adds that about $18.8 billion was spent on the program between 2003 and 2008 and that Congress and former President George W. Bush last year authorized $48 billion for PEPFAR over five years. Obama's plan "boosts" global health spending to $63 billion over six years, the editorial says, adding, "PEPFAR would receive the bulk of the funding ($51 billion). The rest would be aimed at averting unintended pregnancies and eliminating some tropical diseases."

According to the editorial, "[e]fforts to end deaths from AIDS will continue to fail until ways are found to slow and eventually halt the number of HIV infections. This task will fall to Dr. Eric Goosby," who earlier this month was named U.S. global AIDS coordinator. "For more than 25 years, Dr. Goosby has fought the epidemic," the editorial says, concluding, "He has helped develop and implement major treatment programs in South Africa, Rwanda, China and Ukraine. Given this vast experience, Mr. Goosby must make it a priority to find ways to bring down the rates of HIV infection" (Washington Post, 5/7).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024